The data-entry/completion deadline for each report is exactly one day prior to the data cut date given in the link below.
VQI Regional Quality Reports (Semi-Annual)
The regional quality reports are the cornerstone of the SVS VQI’s spring and fall regional quality group meetings. These reports show centers where they stand in comparison to other centers in their region and to all centers in the SVS VQI on these 23 key measures:
- Multiple registries: Long-Term Follow-up
- Multiple registries: Discharge Medications
- TFEM CAS ASYMP: Stroke/Death
- TFEM CAS SYMP: Stroke/Death
- TCAR ASYMP: Stroke/Death
- TCAR SYMP: Stroke/Death
- CEA ASYMP: Stroke/Death
- CEA ASYMP: Postop LOS>1 Day
- CEA SYMP: Stroke/Death
- CEA SYMP: Postop LOS>1 Day
- EVAR: Postop LOS>2 Days
- EVAR: Sac Diameter Reporting
- EVAR: SVS Sac Size Guideline
- TEVAR: Sac Diameter Reporting
- OAAA: In-Hospital Mortality
- OAAA: SVS Cell-Saver Guideline
- OAAA: SVS Iliac Inflow Guideline
- PVI: ABI/Toe Pressure
- INFRA: Major Complications
- SUPRA: Major Complications
- LEAMP: Postop Complications
- AVACCESS: Primary AVF vs. Graft
- IVCF: Filter Retrieval Reporting
Each of these reports provides information on the center’s performance during the previous year and over the past 4 years, comparing the center’s rates with the rates of other centers in the region and all centers in the SVS VQI.
VQI Best Practices Dashboards (Quarterly)
The Best Practices Dashboards provide each center with its rate on more than 200 outcomes (including results for the DC Medications national quality initiative) and process measures across 12 SVS VQI registries, comparing that rate with regional and national benchmarks. Color-coding is provided to make it easy for center staff to whether they are in the top 25% of all centers (green) or the bottom 25% (red). The outcomes reported in the dashboards are chosen by the governing committees for each registry and include results for the DC Medications national quality initiative.
Quality Initiative Updates (Quarterly)
The SVS PSO, in consultation with the Arterial Quality Council, selects SVS VQI-wide quality improvement initiatives. The goals of these initiatives are publicized to all member centers and discussed at spring and fall regional quality meetings. Current measures are prescription of antiplatelet and statin at discharge after all vascular procedures, and reporting of sac diameters between 9-21 months after EVAR. Performance updates on the quality initiatives are delivered quarterly to each center, giving each center its progress to date on these initiatives along with national benchmarks. The QI updates provide rapid data-feedback for centers to evaluate their data in preparation for the yearly participation awards, where centers can earn additional credit for exemplary participation in national quality improvement initiatives.